Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07209397 · ClinicalTrials.gov registry record · NA

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

A NA study of Overactive Bladder and Overactive Bladder (OAB), sponsored by InMode MD.

Recruiting
Registry status
NA
Development phase
202
Enrollment target
9
Study locations

NCT07209397 is a NA study of Overactive Bladder and Overactive Bladder (OAB) that is actively recruiting participants, run by InMode MD. The registered enrollment target is 202 participants, roughly in line with the 207-participant average among 45 other Overactive Bladder trials with a reported enrollment target. The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07209397, a NA study of Overactive Bladder and Overactive Bladder (OAB), is actively recruiting participants, sponsored by InMode MD.

RECRUITING
Registry status
NA
Development phase
202 participants
Enrollment target
9
Study locations

Study Summary

The goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have had OAB symptoms for at least 6 months. The main questions it aims to answer are: Does the MORPHEUSV device lower the number of daily episodes of accidental urine leakage caused by urgency? Does it work better than a sham (placebo) treatment? Researchers will compare the MORPHEUSV device to a sham treatment to see how well it reduces symptoms of overactive bladder. Participants will: 1) Receive one session of either the MORPHEUSV or sham treatment. 2) Track their symptoms using a diary and questionnaires 3) Return for three to six follow-up visits over 12 months. This study is being conducted at multiple clinics in the United States.

Conditions Studied

Overactive Bladder Overactive Bladder (OAB) Urge Urinary Incontinence Mixed Urinary Incontinence Mixed Urinary Incontinence (Urge-Predominant) Idiopathic Overactive Bladder With Urinary Incontinence Idiopathic Overactive Bladder

Interventions

  • DEVICE Detrusor nerve radiofrequency ablation
  • DEVICE Simulated (sham) detrusor nerve radiofrequency ablation

Study Locations (9)

California

  • Stanford Medicine Department of Obstetrics & Gynecology - Palo Alto

District of Columbia

  • MedStar Health Research Institute - Washington D.C.

Idaho

  • Advanced Specialty Research - Boise

Illinois

  • University of Chicago Medicine Urogynecology - Chicago

Kansas

  • Cypress Medical Research Center - Wichita

Massachusetts

  • Bay State Clinical Trials - Watertown

Nebraska

  • Urology Center, P.C. - Omaha

Nevada

  • UNLV Kirk Kerkorian School of Medicine Department of Gynecologic Surgery & Obstetrics - Las Vegas

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2025-11-25
Est. Completion 2027-11-30
Phase NA

Sponsor

InMode MD

22 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07209397

The ClinicalTrials.gov registry entry for NCT07209397 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 207-participant average among 45 other Overactive Bladder trials with a reported enrollment target. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Detrusor nerve radiofrequency ablation is the first listed.

NCT07209397 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, District of Columbia, Idaho.

Frequently Asked Questions

What is clinical trial NCT07209397 about?

NCT07209397 is a clinical study titled "Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women". The goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have had OAB symptoms for ...

What is the current status of trial NCT07209397?

This trial is currently recruiting. It is a NA study. The enrollment target is 202 participants. The study started on 2025-11-25. Estimated completion is 2027-11-30.

What conditions does trial NCT07209397 study?

This clinical trial studies the following conditions: Overactive Bladder, Overactive Bladder (OAB), Urge Urinary Incontinence, Mixed Urinary Incontinence, Mixed Urinary Incontinence (Urge-Predominant).

What interventions are being tested in trial NCT07209397?

The interventions under investigation include: Detrusor nerve radiofrequency ablation (DEVICE), Simulated (sham) detrusor nerve radiofrequency ablation (DEVICE).

Who is sponsoring clinical trial NCT07209397?

This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07209397 being conducted?

This trial has 9 study locations across California, District of Columbia, Idaho, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overactive Bladder

All registered trials for this condition

Overactive Bladder (OAB)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.